Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCHP vs GSK✓SelectedUSD · GSKMCHP vs GSK performance historyLatest closeAs of+1.35%11/17
Stock and ETF performance explorer

MCHP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+33,932.9%
GSK return
+1,040.2%
Excess return
+32,892.7%
Maximum drawdown
-63.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%-2.3%+3.7%+2.2%
7D-1.5%-3.0%+1.5%-0.4%
30D-19.5%+0.4%-19.9%-19.8%
3M-25.5%-1.2%-24.3%-25.6%
6M-36.0%+0.9%-36.9%-37.1%
YTD-5.1%+4.0%-9.1%-8.4%
1Y+18.0%+7.3%+10.7%+12.6%
3Y-23.3%+57.1%-80.3%-38.4%
5Y-20.0%+43.0%-63.0%-34.5%
10Y+118.2%+103.1%+15.1%+56.4%
All+33,932.9%+1,040.2%+32,892.7%+16,637.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling